Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter E Light

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Circulation. Cardiovascular Genetics|December 25, 2009
Distinct early signaling events resulting from the expression of the PRKAG2 R302Q mutant of AMPK contribute to increased myocardial glycogenKaralyn D Folmes, Anita Y M Chan, Debby P Y Koonen, et al.
Diabetes|March 20, 2010
Alterations in skeletal muscle fatty acid handling predisposes middle-aged mice to diet-induced insulin resistanceDebby P Y Koonen, Miranda M Y Sung, Cindy K C Kao, et al.
British Journal of Pharmacology|October 10, 2013
Characterization of a novel multifunctional resveratrol derivative for the treatment of atrial fibrillationIstvan Baczko, David Liknes, Wei Yang, et al.
Circulation|April 9, 2021
Cardiac Late Sodium Channel Current Is a Molecular Target for the Sodium/Glucose Cotransporter 2 Inhibitor EmpagliflozinKoenraad Philippaert, Subha Kalyaanamoorthy, Mohammad Fatehi, et al.
Diabetes|October 15, 2011
Islet cholesterol accumulation due to loss of ABCA1 leads to impaired exocytosis of insulin granulesJanine K Kruit, Nadeeja Wijesekara, Jocelyn E Manning Fox, et al.
Cell Metabolism|June 8, 2017
N-acyl Taurines and Acylcarnitines Cause an Imbalance in Insulin Synthesis and Secretion Provoking β Cell Dysfunction in Type 2 DiabetesMichaela Aichler, Daniela Borgmann, Jan Krumsiek, et al.
Circulation. Heart Failure|January 21, 2020
Empagliflozin Blunts Worsening Cardiac Dysfunction Associated With Reduced NLRP3 (Nucleotide-Binding Domain-Like Receptor Protein 3) Inflammasome Activation in Heart FailureNikole J Byrne, Nobutoshi Matsumura, Zaid H Maayah, et al.
The Journal of Clinical Investigation|October 5, 2013
2-Aminoadipic acid is a biomarker for diabetes riskThomas J Wang, Debby Ngo, Nikolaos Psychogios, et al.
Cell Metabolism|February 2, 2022
Heterogenous impairment of α cell function in type 2 diabetes is linked to cell maturation stateXiao-Qing Dai, Joan Camunas-Soler, Linford J B Briant, et al.
BMC Cardiovascular Disorders|July 27, 2014
The Alberta Heart Failure Etiology and Analysis Research Team (HEART) studyJustin A Ezekowitz, Harald Becher, Israel Belenkie, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Circulation. Cardiovascular Genetics|December 25, 2009
Distinct early signaling events resulting from the expression of the PRKAG2 R302Q mutant of AMPK contribute to increased myocardial glycogenKaralyn D Folmes, Anita Y M Chan, Debby P Y Koonen, et al.
Diabetes|March 20, 2010
Alterations in skeletal muscle fatty acid handling predisposes middle-aged mice to diet-induced insulin resistanceDebby P Y Koonen, Miranda M Y Sung, Cindy K C Kao, et al.
British Journal of Pharmacology|October 10, 2013
Characterization of a novel multifunctional resveratrol derivative for the treatment of atrial fibrillationIstvan Baczko, David Liknes, Wei Yang, et al.
Circulation|April 9, 2021
Cardiac Late Sodium Channel Current Is a Molecular Target for the Sodium/Glucose Cotransporter 2 Inhibitor EmpagliflozinKoenraad Philippaert, Subha Kalyaanamoorthy, Mohammad Fatehi, et al.
Diabetes|October 15, 2011
Islet cholesterol accumulation due to loss of ABCA1 leads to impaired exocytosis of insulin granulesJanine K Kruit, Nadeeja Wijesekara, Jocelyn E Manning Fox, et al.
Cell Metabolism|June 8, 2017
N-acyl Taurines and Acylcarnitines Cause an Imbalance in Insulin Synthesis and Secretion Provoking β Cell Dysfunction in Type 2 DiabetesMichaela Aichler, Daniela Borgmann, Jan Krumsiek, et al.
Circulation. Heart Failure|January 21, 2020
Empagliflozin Blunts Worsening Cardiac Dysfunction Associated With Reduced NLRP3 (Nucleotide-Binding Domain-Like Receptor Protein 3) Inflammasome Activation in Heart FailureNikole J Byrne, Nobutoshi Matsumura, Zaid H Maayah, et al.
The Journal of Clinical Investigation|October 5, 2013
2-Aminoadipic acid is a biomarker for diabetes riskThomas J Wang, Debby Ngo, Nikolaos Psychogios, et al.
Cell Metabolism|February 2, 2022
Heterogenous impairment of α cell function in type 2 diabetes is linked to cell maturation stateXiao-Qing Dai, Joan Camunas-Soler, Linford J B Briant, et al.
BMC Cardiovascular Disorders|July 27, 2014
The Alberta Heart Failure Etiology and Analysis Research Team (HEART) studyJustin A Ezekowitz, Harald Becher, Israel Belenkie, et al.
Pageof 8